Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.
Periodontopathic bacteria in English HIV-seropositive persons.
AIDS Patient Care STDS. 1999 Jun;13(6):369-74. Unique Identifier : AIDSLINE MED/20301675 Scully C; Porter SR; Mutlu S; Epstein JB; Glover S; Kumar N; Department of Oral Medicine, Eastman Dental Institute, University; of London, England. CScully@eastman.ucl.ac.uk
Abstract:
Selected periodontopathic bacteria were sought in 20 HIV-infected English patients and eight noninfected control subjects with similar periodontal status, using highly specific DNA probes. Actinobacillus actinomycetemcomitans (A. a), Porphyromonas gingivalis, Campylobacter rectus, Prevotella intermedia, and Fusobacterium nucleatum were more frequently detected and were found at higher levels in HIV-infected individuals than in controls. Significantly increased levels of Treponema denticola but, in contrast, lower levels of Eikenella corrodens were found in nonbleeding sites of HIV-infected patients compared with controls. The results of the present investigation on English patients suggest a periodontopathogenic role for A. a, P. gingivalis and C. rectus, and possibly P. intermedia and are in general accord with most previously reported data from the United States. Longitudinal studies are now required to determine more precisely the association between periodontopathic microflora, immune competence and periodontal health and disease in HIV-infected persons.
Keywords: CLINICAL TRIAL CONTROLLED CLINICAL TRIAL JOURNAL ARTICLE Adult AIDS-Related Opportunistic Infections/DIAGNOSIS/EPIDEMIOLOGY/ *MICROBIOLOGY Comparative Study Disease Progression England/EPIDEMIOLOGY Female Fungi/*ISOLATION & PURIF Gram-Negative Bacteria/*ISOLATION & PURIF Gram-Positive Bacteria/*ISOLATION & PURIF Human HIV Seropositivity Incidence Male Middle Age Periodontitis/DIAGNOSIS/EPIDEMIOLOGY/*MICROBIOLOGY Risk Factors
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from
Elton John AIDS Foundation,
the National Library of Medicine,
and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.